Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$2.08 - $7.2 $6,672 - $23,097
-3,208 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$6.63 - $16.05 $5,768 - $13,963
-870 Reduced 21.33%
3,208 $23,000
Q4 2021

Feb 15, 2022

BUY
$9.69 - $25.11 $39,515 - $102,398
4,078 New
4,078 $65,000

Others Institutions Holding XLO

About Xilio Therapeutics, Inc.


  • Ticker XLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,471,600
  • Market Cap $35.2M
  • Description
  • Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine prog...
More about XLO
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.